Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan · Delayed Price · Currency is TWD 54.50
+4.90 (9.88%)
At close: Mar 23, 2026
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 17.92 billion as of March 23, 2026. Its market cap has increased by 4.61% in one year.
Market Cap
17.92B
Enterprise Value
16.43B
Revenue
613.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
54.50
Market Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 17.92B, an increase of 531.99%. That is a compound annual growth rate of 18.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 17.92B | 44.37% |
| Dec 31, 2025 | 12.41B | 4.72% |
| Dec 31, 2024 | 11.85B | -48.55% |
| Dec 29, 2023 | 23.04B | 1.10% |
| Dec 30, 2022 | 22.78B | -64.20% |
| Dec 30, 2021 | 63.65B | 192.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 24.88B |
| Lumosa Therapeutics | 24.29B |
| Sunmax Biotechnology | 21.38B |
| Polaris Group | 17.11B |
| EirGenix | 17.10B |
| AP Biosciences | 15.79B |
| TaiMed Biologics | 13.26B |
| Ever Supreme Bio Technology | 12.39B |